Phase III trial investigating the long-term (1 -yeear) tolerability and efficacy of telapristone
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2009
At a glance
- Drugs Telapristone (Primary)
- Indications Endometriosis; Uterine leiomyoma
- Focus Adverse reactions
- Sponsors Repros Therapeutics
- 03 Aug 2009 Status changed from not yet recruiting to suspended, according to a Repros Therapeutics media release.
- 02 Sep 2008 New trial record.